ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,321Medicare Part D Prescriptions Filled, Including Refills

Rank: 412 out of 2482

$433K Total Retail Price of All Prescriptions

Rank: 421 out of 2482

321 Patients Receiving at Least One Drug in Part D
73% Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Illinois
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 321 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

19% of this provider’s 321 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LISINOPRIL 369 277 76 1 2
LEVOTHYROXINE SODIUM 300 216 45 2 1
HYDROCODONE-ACETAMINOPHEN 248 130 56 S3 3 6
METOPROLOL SUCCINATE 243 221 38 4 13
SIMVASTATIN 234 191 43 5 3
AMLODIPINE BESYLATE 224 188 42 6 4
FUROSEMIDE 209 145 40 7 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 199 137 35 8 32
ATORVASTATIN CALCIUM 178 139 34 9 9
PRAVASTATIN SODIUM 168 126 35 10 15
METFORMIN HCL ER 142 90 33 11 69
METOPROLOL TARTRATE 141 98 28 12 10
GLIMEPIRIDE 141 109 24 12 47
NAMENDA 133 98 12 14 28
OMEPRAZOLE 127 104 29 15 7
WARFARIN SODIUM 124 110 19 16 12
CLOPIDOGREL 119 100 21 17 16
CARVEDILOL 107 102* 24 18 22
DONEPEZIL HCL 104 85 18 19 31
HYDROCHLOROTHIAZIDE 103 98* 25 20 11
SERTRALINE HCL 100 45 15 21 25
METFORMIN HCL 98 70 20 22 8
PANTOPRAZOLE SODIUM 84 58 22 23 24
POTASSIUM CHLORIDE 82 70 18 24 14
TAMSULOSIN HCL 79 74* 17 25 27
FAMOTIDINE* 77 14 12 26 48
VENLAFAXINE HCL ER 69 <11 <11 27 99
TRAZODONE HCL 68 63* 14 28 46
NAPROXEN 64 32 14 29 76
FLUTICASONE PROPIONATE 64 42 20 29 39
SPIRONOLACTONE 63 <11 <11 31 64
TRAMADOL HCL 63 46 16 31 20
LOSARTAN POTASSIUM 61 <11 <11 33 19
NEXIUM 61 50 11 33 44
ATENOLOL 57 52* 13 35 18
JANUVIA 56 <11 <11 36 57
AMITRIPTYLINE HCL 55 19 12 R 37 74
ESCITALOPRAM OXALATE 55 <11 <11 37 50
CARBIDOPA-LEVODOPA 55 <11 <11 37 106
FENOFIBRATE* 52 <11 <11 40 53
QUETIAPINE FUMARATE 52 <11 <11 A 40 65
CITALOPRAM HBR 52 28 15 40 23
MONTELUKAST SODIUM 52 <11 <11 40 43
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 10, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.